1,417 Shares in The Clorox Company (NYSE:CLX) Purchased by Wealth Group Ltd

Wealth Group Ltd purchased a new stake in shares of The Clorox Company (NYSE:CLX) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,417 shares of the company’s stock, valued at approximately $231,000.

A number of other hedge funds have also recently bought and sold shares of CLX. Van ECK Associates Corp boosted its holdings in shares of Clorox by 1,715.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after buying an additional 1,380,724 shares during the last quarter. Nuance Investments LLC increased its stake in shares of Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock worth $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Parsifal Capital Management LP bought a new position in Clorox during the fourth quarter worth about $128,245,000. Confluence Investment Management LLC bought a new position in shares of Clorox during the 1st quarter worth approximately $135,630,000. Finally, Wulff Hansen & CO. raised its stake in Clorox by 13,547.0% in the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after acquiring an additional 436,891 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 0.2 %

Shares of NYSE:CLX opened at $159.53 on Thursday. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a market capitalization of $19.81 billion, a PE ratio of 82.66, a price-to-earnings-growth ratio of 3.31 and a beta of 0.41. The company has a fifty day moving average of $156.55 and a 200-day moving average of $144.65.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. On average, equities analysts predict that The Clorox Company will post 6.63 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. The ex-dividend date of this dividend is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.06%. Clorox’s dividend payout ratio is presently 252.85%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CLX shares. TD Cowen initiated coverage on shares of Clorox in a report on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Wells Fargo & Company decreased their target price on Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a research report on Wednesday, July 10th. Finally, Barclays boosted their target price on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Six analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus price target of $146.13.

Insiders Place Their Bets

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.51% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.